Log in
Log in
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
Sign up
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
  1. Homepage
  2. Equities
  3. United States
  4. Nyse
  5. Pfizer, Inc.
  6. Summary
    PFE   US7170811035

PFIZER, INC.

(PFE)
  Report
Delayed Nyse  -  04:03 2022-09-26 pm EDT
43.83 USD   -0.57%
05:12pHealth Care Down as Investors Flee Defensive Sectors -- Health Care Roundup
DJ
02:30pTranscript : Pfizer Inc. - Special Call
CI
01:43pPfizer seeks to expand omicron booster to 5- to 11-year-olds
AQ
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisionsFunds 
Quotes 5-day view   Delayed Quote. Delayed Nyse
09/20/2022 09/21/2022 09/22/2022 09/23/2022 09/26/2022 Date
44.77(c) 43.92(c) 44.57(c) 44.08(c) 43.83 Last
15 368 999 17 505 210 18 508 104 18 871 669 18 680 218 Volume
-1.47% -1.90% +1.48% -1.10% -0.57% Change
More quotes
Estimated financial data (e) (USD)
Sales 2022 102 B - -
Net income 2022 32 739 M - -
Net cash position 2022 10 262 M - -
P/E ratio 2022 7,74x
Yield 2022 3,70%
Sales 2023 77 219 M - -
Net income 2023 22 513 M - -
Net cash position 2023 23 510 M - -
P/E ratio 2023 10,5x
Yield 2023 3,82%
Capitalization 246 B 246 B -
EV / Sales 2022 2,32x
EV / Sales 2023 2,88x
Nbr of Employees 79 000
Free-Float 59,0%
More Financials
Company
Pfizer, Inc. the world's leading pharmaceutical group. Net sales break down by family of products as follows: - vaccines (52.4%); - drugs for the treatment of cancer (15.2%); - cardiovascular, metabolic and analgesic drugs (11.5%); - injectable, anti-infectives drugs and active pharmaceutical ingredients (9%); - drugs for inflammatory and immune diseases (5.5%); - drugs for rare diseases (4.4%); - other... 
Sector
Pharmaceuticals
Calendar
09/26 | 02:30pmAnalyst Meeting - Climate Action
More about the company
Ratings of Pfizer, Inc.
Trading Rating : 
Investor Rating : 
ESG Refinitiv : 
C+
More Ratings
All news about PFIZER, INC.
05:12pHealth Care Down as Investors Flee Defensive Sectors -- Health Care Roundup
DJ
02:30pTranscript : Pfizer Inc. - Special Call
CI
01:43pPfizer seeks to expand omicron booster to 5- to 11-year-olds
AQ
01:01pIn 4 Weeks Meet Pfizer, AstraZeneca, DiME & Many More at the Biosensors for Medical Wea..
AQ
12:10pWhat Is DE&I? Why It Matters?
AQ
09:30aCapitulation ahead?
MS
09:09aSector Update: Health Care Stocks Mixed Premarket Monday
MT
08:42aPfizer, BioNTech Seek FDA Approval for COVID-19 Vaccine Targeting Omicron Subvariants i..
MT
08:33aTrending : Pfizer, BioNTech Seek OK for Covid-19 Booster in Kids
DJ
07:31aPfizer, BioNTech Submit US FDA Emergency Use Application For Omicron-Adapted Vaccine Fo..
MT
07:20aPfizer/BioNTech seek FDA nod for new COVID boosters for children
RE
07:05aPfizer, BioNTech File FDA Application for Emergency Use Authorization of Omicron-Specif..
MT
06:54aPfizer seeks FDA nod for Omicron-retooled booster for kids aged 5-11 yrs
RE
06:46aPfizer and BioNTech Submit Application to U.S. FDA for Emergency Use Authorization of O..
BU
05:42aPfizer, BioNTech Ask FDA to Approve Booster for Children
DJ
More news
News in other languages on PFIZER, INC.
04:16pMÄRKTE USA/Erneute Abgaben - Dow-Jones im "Bärenmarkt"
12:26pMÄRKTE USA/Uneinheitlich - Volatilität mit Rezessionssorgen weiter hoch
09:48aMÄRKTE USA/Börsen starten mit leichten Abschlägen
09:09aMise à jour sectorielle : Les actions du secteur de la santé son..
09:02aLes valeurs à suivre aujourd'hui à Wall Street - Lundi 26 septembre 2022
More news
Analyst Recommendations on PFIZER, INC.
More recommendations
Stock Trading Strategies
PFIZER, INC. - 03/07
The comeback of an upward trend can be anticipated
BUY
More Stock Trading Analysis
ETFs positioned on PFIZER, INC.ETFs and Trackers with Trackinsight
ETF WeightVar. 5daysRatingGeography
Nomura NEXT FUNDS International Equity MSCI...9.37%-4.43%-World
IShares U.S. Healthcare ETF - USD5.94%-3.65%-NC
SPDR S&P U.S. Health Care Select Sector - USD5.69%-3.65%United_States
The Health Care Select Sector SPDR Fund - USD5.69%-3.70%United_States
IShares S&P 500 Health Care Sector EUR Hed...5.66%-2.89%-United_States
More ETFs positioned on PFIZER, INC.
Chart PFIZER, INC.
Duration : Period :
Pfizer, Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends PFIZER, INC.
Short TermMid-TermLong Term
TrendsBearishBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 22
Last Close Price 43,83 $
Average target price 55,75 $
Spread / Average Target 27,2%
EPS Revisions
Managers and Directors
Albert Bourla Chairman, Chief Executive & Operating Officer
David M. Denton Chief Financial Officer & Executive Vice President
Mikael Dolsten Executive VP, President-Research & Development
Lidia L. Fonseca Executive VP, Chief Digital & Technology Officer
Aida Habtezion Chief Medical Officer
Sector and Competitors
1st jan.Capi. (M$)
PFIZER, INC.-25.77%247 392
JOHNSON & JOHNSON-3.14%438 337
ELI LILLY AND COMPANY12.76%295 941
ROCHE HOLDING AG-18.41%259 291
ABBVIE INC.5.66%252 944
NOVO NORDISK A/S1.95%221 838